NRXS logo

NRXSNeuraxis Inc

$6.94
$0.00
(0.00%)
Today
Closed $6.80
$0.14
(2.06%)
After Hours
Updated: 06:06 PM EDT
Mkt Cap$84.21M
Vol61,810.00
News
all
press releases
NeurAxis Stock Gains Post Q1 Earnings, Revenues and Margin Surge Y/Y
NRXS' first-quarter 2026 results show surging revenue and expanding gross margin as reimbursement improves under the Category I CPT code.
Zacks
News Placeholder
More News
News Placeholder
The Zacks Analyst Blog Highlights Alphabet, Walmart, Micron Technology and NeurAxis
Alphabet, Walmart and Micron lead Zacks research as AI growth, retail strength and memory demand drive performance, while risks linger.
Zacks
News Placeholder
Top Stock Reports for Alphabet, Walmart & Micron
Alphabet rides AI-driven growth across Search, Cloud and subscriptions, but rising spending, debt and legal risks temper near-term flexibility.
Zacks
News Placeholder
NeurAxis Stock Gains Post Q4 Earnings on Strong Revenue Growth
NRXS witnesses strong revenue growth and expanding coverage in fourth-quarter 2025, but rising costs and commercialization investments weigh on profitability.
Zacks
News Placeholder
The Zacks Analyst Blog Meta, Bank of America, The Procter & Gamble, Espey and NeurAxis
Meta Platforms leads today???s Zacks Research Daily as AI-driven engagement and ad demand fuel growth, even as heavy AI investments raise monetization concerns.
Zacks
News Placeholder
Top Stock Reports for Meta, Bank of America & Procter & Gamble
Meta Platforms leads today's Zacks Research Daily as analysts highlight strong user growth, heavier AI investment and lingering concerns around monetization.
Zacks
News Placeholder
NRXS Stock Declines Post Q3 Earnings Despite Continued Revenue Growth
NeurAxis posts its fifth straight quarter of double-digit expansion, but rising costs and margin pressure weigh on third-quarter 2025 results.
Zacks
News Placeholder
The Zacks Analyst Blog Highlights Alphabet, IBM, Merck, SandRidge Energy and NeurAxis
Zacks highlights Alphabet, IBM, Merck, SandRidge Energy, and NeurAxis, providing research insights on their growth prospects, market performance, and key risks for investors.
Zacks
News Placeholder
Top Research Reports for Alphabet, IBM & Merck
Alphabet, IBM, and Merck headline Zacks' latest research reports, with insights spanning AI, cloud growth, and pipeline challenges.
Zacks
News Placeholder
NeurAxis Stock Down Following Q2 Earnings Despite Revenue Growth
NRXS reports strong second-quarter 2025 revenue growth and lower losses, but gross margin compression remains a key concern.
Zacks
<
1
2
...
>

Advertisement|Remove ads.